A Study to Evaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic Seizures
Clinical trial NCT04202159 · COMPLETED
Trial details
- NCT number
- NCT04202159
- Sponsor
- Eisai GmbH
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-01-21
- Primary completion
- 2023-03-31
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.